Intuitive Surgical, Inc. LSE:0R29.L

Intuitive Surgical stock price today

$358.08
-176.02
-32.96%
Financial Health
0
1
2
3
4
5
6
7
8
9

Intuitive Surgical stock price monthly change

+19.68%
month

Intuitive Surgical stock price quarterly change

+19.68%
quarter

Intuitive Surgical stock price yearly change

+58.69%
year

Intuitive Surgical key metrics

Market Cap
186.34B
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
5.64
Revenue
7.31B
EBITDA
2.18B
Income
1.98B
Revenue Q/Q
11.46%
Revenue Y/Y
13.80%
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
29.92%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Intuitive Surgical stock price history

Intuitive Surgical stock forecast

Intuitive Surgical financial statements

Intuitive Surgical, Inc. (LSE:0R29.L): Profit margin
Jun 2023 1.75B 420.8M 23.96%
Sep 2023 1.74B 415.7M 23.84%
Dec 2023 1.92B 606.2M 31.44%
Mar 2024 1.89B 544.9M 28.82%
Intuitive Surgical, Inc. (LSE:0R29.L): Analyst Estimates
Sep 2025 2.29B 669.46M 29.11%
Oct 2025 2.30B 671.39M 29.15%
Dec 2025 2.50B 712.05M 28.46%
Mar 2026 2.45B 692.14M 28.14%
  • Analysts Price target

  • Financials & Ratios estimates

Intuitive Surgical, Inc. (LSE:0R29.L): Earnings per share (EPS)
2024-10-17 1.64 1.56
Intuitive Surgical, Inc. (LSE:0R29.L): Debt to assets
Jun 2023 13903300000 1.94B 13.98%
Sep 2023 14712700000 2.08B 14.2%
Dec 2023 15441500000 2.04B 13.24%
Mar 2024 15828000000 1.78B 11.26%
Intuitive Surgical, Inc. (LSE:0R29.L): Cash Flow
Jun 2023 665.7M 557.6M 63.3M
Sep 2023 548.4M -446.6M 61.8M
Dec 2023 228.3M -1.04B -31.5M
Mar 2024 38.8M -128.5M 179.9M

Intuitive Surgical alternative data

Intuitive Surgical, Inc. (LSE:0R29.L): Employee count
Aug 2023 12,120
Sep 2023 12,120
Oct 2023 12,120
Nov 2023 12,120
Dec 2023 12,120
Jan 2024 12,120
Feb 2024 13,676
Mar 2024 13,676
Apr 2024 13,676
May 2024 13,676
Jun 2024 13,676
Jul 2024 13,676

Intuitive Surgical other data

Insider Compensation
Dr. Gary S. Guthart (1966) Pres, Chief Executive Officer & Director $1,600,000
Mr. David J. Rosa (1968) Executive Vice President & Chief Bus. Officer $1,000,000
Mr. Salvatore J. Brogna (1955) Consultant & Advisor
$992,700
Mr. Marshall L. Mohr (1956) Executive Vice President & Chief Financial Officer
$935,100
Dr. Myriam J. Curet McAdams F.A.C.S., M.D. (1957) Executive Vice President & Chief Medical Officer
$827,720
Mr. Craig Child Senior Vice President of HR
Mr. Julian Nikolchev Senior Vice President of Corporation Devel. & Strategy
Ms. Kara Andersen Reiter Senior Vice President, Gen. Counsel & Chief Compliance Officer
Calvin Darling Senior Director of IR
Mr. Jamie E. Samath Senior Vice President of Fin. & Principal Accounting Officer
  • What's the price of Intuitive Surgical stock today?

    One share of Intuitive Surgical stock can currently be purchased for approximately $358.08.

  • When is Intuitive Surgical's next earnings date?

    Intuitive Surgical, Inc. is estimated to report earnings on Wednesday, 15 Oct 2025.

  • Does Intuitive Surgical pay dividends?

    No, Intuitive Surgical does not pay dividends.

  • How much money does Intuitive Surgical make?

    Intuitive Surgical has a market capitalization of 186.34B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 14.49% to 7.12B US dollars. Intuitive Surgical earned 1.8B US dollars in net income (profit) last year or $1.56 on an earnings per share basis.

  • What is Intuitive Surgical's stock symbol?

    Intuitive Surgical, Inc. is traded on the LSE under the ticker symbol "0R29.L".

  • What is Intuitive Surgical's primary industry?

    Company operates in the Healthcare sector and Medical - Equipment & Services industry.

  • How do i buy shares of Intuitive Surgical?

    Shares of Intuitive Surgical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Intuitive Surgical's key executives?

    Intuitive Surgical's management team includes the following people:

    • Dr. Gary S. Guthart Pres, Chief Executive Officer & Director(age: 59, pay: $1,600,000)
    • Mr. David J. Rosa Executive Vice President & Chief Bus. Officer(age: 57, pay: $1,000,000)
    • Mr. Salvatore J. Brogna Consultant & Advisor(age: 70, pay: $992,700)
    • Mr. Marshall L. Mohr Executive Vice President & Chief Financial Officer(age: 69, pay: $935,100)
    • Dr. Myriam J. Curet McAdams F.A.C.S., M.D. Executive Vice President & Chief Medical Officer(age: 68, pay: $827,720)
    • Mr. Craig Child Senior Vice President of HR
    • Mr. Julian Nikolchev Senior Vice President of Corporation Devel. & Strategy
    • Ms. Kara Andersen Reiter Senior Vice President, Gen. Counsel & Chief Compliance Officer
    • Calvin Darling Senior Director of IR
    • Mr. Jamie E. Samath Senior Vice President of Fin. & Principal Accounting Officer
  • How many employees does Intuitive Surgical have?

    As Jul 2024, Intuitive Surgical employs 13,676 workers.

  • When Intuitive Surgical went public?

    Intuitive Surgical, Inc. is publicly traded company for more then 10 years since IPO on 7 Nov 2014.

  • What is Intuitive Surgical's official website?

    The official website for Intuitive Surgical is intuitive.com.

  • Where are Intuitive Surgical's headquarters?

    Intuitive Surgical is headquartered at 1020 Kifer Road, Sunnyvale, CA.

  • How can i contact Intuitive Surgical?

    Intuitive Surgical's mailing address is 1020 Kifer Road, Sunnyvale, CA and company can be reached via phone at +40 85232100.

Intuitive Surgical company profile:

Intuitive Surgical, Inc.

intuitive.com
Exchange:

LSE

Full time employees:

13,676

Industry:

Medical - Equipment & Services

Sector:

Healthcare

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

1020 Kifer Road
Sunnyvale, CA 94086-5304

:
ISIN: US46120E6023
: